In October 2008, a new influenza vaccine became available in Russia.
For the first time in Russia, a preservative-free vaccine in an advanced dosage form, i.e. disposable single-dose syringes, was launched to the market. On September 9th, 2008, Petrovax Group launched production of innovative vaccine Grippol Plus at Petrovax’s new manufacturing site. In mid-October, the company started shipping the first vaccine lots, which means that by the epidemiological season 2008-2009, influenza immunization will be available for the Russian citizens.
The vaccine has already been supplied to many healthcare, educational, and other institutions of the city of Moscow, Moscow region, and other Russian regions.
Grippol Plus is a latest-generation influenza vaccine, an improved Grippol analogue.
The vaccine conforms to the international efficacy, safety, and quality requirements, and it is unrivaled throughout the world. It contains 5 mg of the antigens of the current influenza virus strains (hemagglutinin and neuraminidase) and Polyoxidonium. The vaccine efficacy and safety was studied in double-blind, placebo controlled clinical trials. The medication is produced at an up-to-date facility to international GMP (Good Manufacturing Practice) standards.
Hotline: +7 495 765-81-50.